Becton Dickinson/Millennium Alliance First Step In Therapeutics Strategy
This article was originally published in The Gray Sheet
Executive Summary
Becton Dickinson's partnership with Millennium Pharmaceuticals subsidiary Millennium Predictive Medicine (MPM), announced Feb. 22, is the second of four stages in a newly implemented initiative designed to increase the clinical value of BD's diagnostic products, the firm says.